|
"jensen e h"的相关文件
显示项目 1-2 / 2 (共1页) 1 每页显示[10|25|50]项目
國立成功大學 |
2021 |
Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC
|
Herbst, R.S.;Garon, E.B.;Kim, D.-W.;Cho, B.C.;Gervais, R.;Perez-Gracia, J.L.;Han, J.-Y.;Majem, Majem M.;Forster, M.D.;Monnet, I.;Novello, S.;Gubens, M.A.;Boyer, M.;Su, W.-C.;Samkari, A.;Jensen, E.H.;Kobie, J.;Piperdi, B.;Baas, P. |
國立成功大學 |
2020 |
Long-term outcomes and retreatment among patients with previously treated, programmed death-ligand 1‒positive, advanced non‒small-cell lung cancer in the KEYNOTE-010 study
|
Herbst, R.S.;Garon, E.B.;Dong-Wan, K.;Cho, B.C.;Perez-Gracia, J.L.;Ji-Youn, H.;Arvis, C.D.;Majem, Majem M.;Forster, M.D.;Monnet, I.;Novello, S.;Szalai, Z.;Gubens, M.A.;Wu-Chou, S.;Ceresoli, G.L.;Samkari, A.;Jensen, E.H.;Lubiniecki, G.M.;Baas, P. |
显示项目 1-2 / 2 (共1页) 1 每页显示[10|25|50]项目
|